1. Anastasio NC, Lanfranco MF, Burbar MJ, Seitz PK, Stutz SJ, McGinnis AG, Watson CS, Cunningham KA (2010) Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex. J Neurochem 133:1504–1515
2. Arch JRS (2008) Perspectives from β3-adrenoceptor agonists on pharmacology, physiology and obesity drug discovery. Naunyn-Schmiedeberg’s Arch Pharmacol 378:225–240
3. Arch JR, Wilson S (1996) Prospect for beta3-adrenoceptor agonists in the treatment of obesity and diabetes. Int J Obes Relat Metab Disord 20:191–199
4. Arch JRS, Ainsworth AT, Ellis RD, Piercy V, Thody VE, Thurlby PL, Wilson C, Wilson S, Young P (1984) Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents. Int J Obes 8:1–11
5. Beermann S, Seifert R, Neumann D (2012) Commercially available antibodies against human and murine histamine H4-receptor lack specificity. Naunyn-Schmiedeberg’s Arch Pharmacol 385:125–135